Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related mortality worldwide. Programmed cell death ligand-1 (PD-L1) is an immune checkpoint protein that binds to programmed cell death-1 (PD-1), which is expressed in activated T cells and other immune cells and has been employed in cancer therapy, including HCC. Recently, PD-L1 overexpression has been documented in treatment-resistant cancer cells.
View Article and Find Full Text PDFWe prepared ZnO nanocomposites with WO or CuO nanostructures to improve the photocatalytic performance of ZnO nanostructures. Characterization of the nanocomposites using scanning electron microscopy, x-ray diffraction, UV-vis spectrometry and photoluminescence revealed the morphologies and wide light absorption range of the materials. The highest current densities of WO/ZnO and CuO/ZnO nanocomposites were 1.
View Article and Find Full Text PDF